Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

SELL
$100.18 - $109.02 $300,840 - $327,387
-3,003 Reduced 10.62%
25,275 $2.76 Million
Q3 2023

Oct 12, 2023

SELL
$102.95 - $114.33 $102,641 - $113,987
-997 Reduced 3.41%
28,278 $2.91 Million
Q2 2023

Jul 06, 2023

BUY
$108.61 - $118.38 $103,505 - $112,816
953 Added 3.36%
29,275 $3.38 Million
Q1 2023

Apr 03, 2023

BUY
$102.94 - $114.86 $47,352 - $52,835
460 Added 1.65%
28,322 $3.01 Million
Q4 2022

Feb 07, 2023

SELL
$87.44 - $112.11 $42,933 - $55,046
-491 Reduced 1.73%
27,862 $3.09 Million
Q3 2022

Oct 04, 2022

SELL
$84.53 - $94.96 $33,642 - $37,794
-398 Reduced 1.38%
28,353 $2.44 Million
Q2 2022

Jul 06, 2022

BUY
$83.49 - $94.64 $2.4 Million - $2.72 Million
28,751 New
28,751 $2.62 Million
Q3 2020

Oct 29, 2020

SELL
$73.18 - $82.95 $2.53 Million - $2.87 Million
-34,640 Closed
0 $0
Q2 2020

Jul 13, 2020

SELL
$70.42 - $80.13 $5.64 Million - $6.42 Million
-80,060 Reduced 69.8%
34,640 $2.68 Million
Q1 2020

Apr 06, 2020

SELL
$63.36 - $87.82 $3.98 Million - $5.52 Million
-62,880 Reduced 35.41%
114,700 $8.83 Million
Q4 2019

Jan 14, 2020

SELL
$77.58 - $87.54 $796,746 - $899,035
-10,270 Reduced 5.47%
177,580 $16.2 Million
Q3 2019

Oct 21, 2019

BUY
$76.08 - $82.93 $92,056 - $100,345
1,210 Added 0.65%
187,850 $15.8 Million
Q2 2019

Jul 15, 2019

BUY
$69.84 - $81.59 $7.29 Million - $8.52 Million
104,420 Added 127.0%
186,640 $15.7 Million
Q1 2019

Apr 17, 2019

BUY
$69.58 - $79.36 $195,519 - $223,001
2,810 Added 3.54%
82,220 $6.84 Million
Q4 2018

Jan 14, 2019

BUY
$65.24 - $75.71 $5.18 Million - $6.01 Million
79,410 New
79,410 $5.79 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Centre Asset Management, LLC Portfolio

Follow Centre Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centre Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centre Asset Management, LLC with notifications on news.